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potential confounding in our study. Since this 
was an observational study, we acknowledge this 
possibility. However, we believe that random 
sampling of noncrash road segments, as we used 
for our control, minimizes the chance that such 
confounders substantially influenced the results.
The continuous video collected by NDS allows 
for the precise separation of talking on a cell 
phone with visual–manual tasks associated with 
cell-phone use, which effectively averts any poten-
tial information bias associated with cell-phone 
use while driving. Young’s argument that previ-
ous research that was conducted on the basis of 
cell-phone records was limited to the risk associ-
ated with talking on but not with dialing a cell 
phone has been debated previously.2 In addition, 
others have reported that both the beginning 
and ending of cell-phone conversations, which 
are not reflected in billing records, require risky 
visual–manual tasks.3 Contributing factors lead-
ing to crashes typically unfold over time. Since 
the moment when a crash occurs is difficult to 
match precisely to time stamps in cell-phone 
records, the determination of a proximate cause 
is not possible on the basis of crash reports and 
cell-phone records.
As noted by Boccardi and Paolisso, more re-
search should be done on the effects of secondary-
task involvement on the risk of crashes or near-
crashes for drivers of all ages. We also argue 
that more research on the effects of driver dis-
traction should be conducted on specialty popu-
lations of drivers, including emergency respond-
ers (e.g., police officers and ambulance drivers), 
as well as physicians who are using their vehicle 
as a mobile office. As Silver notes, complex con-
versation is a distraction for drivers, but the ef-
fect of this type of conversation is not yet fully 
understood.
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Sedation and Delirium in Intensive Care
To the Editor: We agree with Reade and Finfer 
(Jan. 30 issue)1 that prevention of delirium in pa-
tients in the intensive care unit (ICU) is clearly 
preferable to treatment after the fact.
Reduction or prevention of sleep deprivation 
may be an additional measure to reduce the risk of 
delirium in the ICU.2 Noise, light, and other fac-
tors may be associated with poor sleep quality. A 
reduction in these factors and promotion of posi-
tive sleep-hygiene behaviors are associated with a 
reduction in the incidence of delirium or coma.3
Because most sedatives degrade sleep architec-
ture, their use may actually increase the risk of 
delirium, rather than reduce it.2 In addition to 
minimizing the use of sedative agents, other 
therapies warrant mention. Critically ill patients 
have a documented loss of a normal circadian 
rhythm associated with melatonin secretion.4 Ex-
ogenous melatonin may be an effective counter-
measure to reduce abnormalities in sleep archi-
tecture, and preliminary data to this effect are 
encouraging.5 Data are lacking from studies to 
evaluate the effects of melatonin on sleep, delir-
ium, and acute brain dysfunction in critically ill 
patients. We hope that future studies of delirium 
in the ICU include this therapy.
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To the Editor: Delirium in patients in acute 
care settings is common, underrecognized, costly, 
and potentially deadly. Pharmacologic approach-
es to prevent or treat it are modestly successful at 
best and have clear potential to harm. In con-
trast, family-based interventions to comfort con-
fused patients predate modern medicine. Their 
use and feasibility are discussed in the medical 
literature,1-3 but data from large, high-quality 
trials are lacking. As volunteer “specialists” who 
know and understand the patient, families are 
often motivated to help prevent and resolve de-
lirium. Future research should focus on this 
common-sense, pragmatic, inexpensive, and hu-
mane approach to prevent and treat delirium.
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The Authors Reply: We agree with Flannery et al. 
that process-of-care interventions to promote 
sleep in critically ill patients are feasible, although 
considerable effort may be required to attain at 
best 60 to 80% compliance.1 Preliminary data 
suggest that such efforts may reduce the inci-
dence of delirium,2 but data from definitive stud-
ies are lacking. More effort is warranted both to 
test the effectiveness of “bundles” of therapies 
for delirium prevention and management (espe-
cially nonpharmacologic approaches) and to op-
timize methods of translating them into routine 
clinical practice. A melatonin agonist approved 
by the Food and Drug Administration has shown 
promise; it was associated with a reduction in the 
incidence and frequency of delirium in a small 
trial in which 24 of the 67 patients enrolled were 
in the ICU.3 Once again, more definitive evidence 
is awaited.
Govig advocates family-based interventions in 
critical illness, and it is highly likely that these 
measures can benefit critically ill patients — as 
has already been shown with family involvement 
in early mobilization.4 However, testing this ap-
proach in clinical trials poses considerable dif-
ficulty, including the assignment of patients to 
a control group with less family involvement. 
Cluster-randomization trials or trials using his-
torical controls could facilitate the encourage-
ment of family involvement without affecting a 
standard-care control group, but they still might 
not allay concerns about external validity. It seems 
obvious that the benefit of family involvement is 
likely and the risk low; thus, without waiting for 
such evidence, we would encourage critical care 
practitioners to afford the families and friends 
of critically ill patients as much access as pos-
sible, when feasible, to involve them in efforts to 
maintain patients’ orientation and normal sleep–
wake cycles, and to assist in early mobilization 
as recovery occurs.
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